Schwanzer-Pfeiffer D et al. reported that the low KIAA0247 level induced a downexpression of CCL2 in response to lipopolysaccharides treatment in vitro [38] and upregulation of CCL2 promotes glioma growth [39]. The gene discussed is CCL2; the disease is glioma.